United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - tolterodine tartrate - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - tolterodine tartrate - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - tolterodine tartrate - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

torrent pharma (uk) ltd - tolterodine tartrate - oral tablet - 2mg

United States - English - NLM (National Library of Medicine)

stat rx usa llc - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 2 mg - detrol tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. detrol tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. detrol is also contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - tolterodine l-tartrate 4 mg - eq. tolterodine 2,74 mg - prolonged-release capsule, hard - 4 mg - tolterodine tartrate 4 mg - tolterodine

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - tolterodine tartrate 1mg equivalent to tolterodine 0.68 mg - film coated tablet - 1 mg - active: tolterodine tartrate 1mg equivalent to tolterodine 0.68 mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white 03f58763 purified water   sodium starch glycolate - arrow – tolterodine 1 & arrow tolterodine 2 are indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - tolterodine tartrate 2mg equivalent to tolterodine 1.37 mg - film coated tablet - 2 mg - active: tolterodine tartrate 2mg equivalent to tolterodine 1.37 mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white 03f58763 purified water   sodium starch glycolate - arrow – tolterodine 1 & arrow tolterodine 2 are indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence.

Canada - English - Health Canada

accord healthcare inc - tolterodine tartrate - capsule (extended release) - 2mg - tolterodine tartrate 2mg - antimuscarinics

Canada - English - Health Canada

accord healthcare inc - tolterodine tartrate - capsule (extended release) - 4mg - tolterodine tartrate 4mg - antimuscarinics